Dr. Shoham-Hazon is a Glaucoma and Advanced Anterior Segment Surgeon (GAASS) based in Miramichi, New Brunswick. He serves as the Director of the Miramichi EyeNB Centre of Excellence and the Medical Director of the Miramichi Surgical Centre of Excellence, a privately owned but publicly
funded ophthalmology operating room.
Dr. Shoham-Hazon completed his fellowship at the University of Toronto. In his leadership roles, he is dedicated to advocating for equality among ophthalmologists working in rural Canada and raising awareness about the unique challenges of rural ophthalmology. He also strives to promote medical school and residency exposure to ophthalmology in rural communities across New Brunswick.
In addition to his clinical work, Dr. Shoham-Hazon is the co-founder and co-CEO of Hexiris, a biotechnology company that has developed a first-of-its-kind MIGS device designed for office-based delivery at the slit lamp, eliminating the need for an operating room.
Dr. Shoham-Hazon holds academic appointments as an Assistant Professor at Dalhousie University and a Clinical Assistant Professor at Memorial University.
Financial disclosure: Dr. Shoham-Hazon has/had an affiliation (financial or otherwise) with a commercial organization:
1. Bausch
2. Bayer
3. Hexiris
4. Nova Eye
5. Roche
Sessions in which Nir Shoham-Hazon participates
Friday 16 June, 2023
This course is designed for general ophthalmologist, glaucoma specialists and residents who wish to expand their surgical skills to optimize glaucoma care for their patients. Surgeons will learn intra-operative gonioscopy techniques to better understand the angle and understand the implantation of various MIGS devices. Featured techniques are the implantation of the iStent inject, implantation of Hydrus Microstent and the use of Kahook...
Sessions in which Nir Shoham-Hazon attends
Friday 16 June, 2023
This course is designed for general ophthalmologist, glaucoma specialists and residents who wish to expand their surgical skills to optimize glaucoma care for their patients. Surgeons will learn intra-operative gonioscopy techniques to better understand the angle and understand the implantation of various MIGS devices. Featured techniques are the implantation of the iStent inject, implantation of Hydrus Microstent and the use of Kahook...
Saturday 17 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Identify Imaging Signs & Biomarkers for ongoing anti-VEGF treatmentIdentify and review pathognomonic imaging features of Inherited Retinal DiseaseReview unique retinal imaging findings in uncommon retinal conditions
Learning ObjectivesAt the end of this session, participants will be able to:Understand how various systemic medication influence glaucomaUnderstand how to manipulate wound healing may improve success in glaucoma surgeryAssess and Integrate various glaucoma surgeries in our management of glaucoma and be aware of some of the c...
Authors: Sunil Ruparelia , Darcie Wilson, Nir Shoham-Hazon. Dalhousie Medical School.Author Disclosures: S. Ruparelia: None. D. Wilson: None. N. Shoham-Hazon: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Abbvie, Bayer, B&L, Iridex, Lightmed, Novartis. Any direct financial payments including rece...
Sunday 18 June, 2023
Learning ObjectivesAt the end of this session, participants will be able to:Understand the change from medication use to other options in glaucoma treatmentUnderstand the latest in laser treatment for glaucoma including the LiGHT and ZAP trials and how to integrate into clinical practiceAssess AI in glaucoma management
Learning ObjectivesAt the end of this session, participants will be able to:Understand and compare various novel devices for glaucoma surgical management including MIGSUnderstand outcomes and potential pitfalls of glaucoma surgeryUnderstand the best candidates for various glaucoma surgeriesCan...
Authors: Shawn Yuan1, Georges Durr1, Joseph Panarelli2. 1Université de Montréal, 2NYU Langone Provider.Author Disclosures: S. Yuan: None. G. Durr: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Alcon Laboratories Inc., Allergan Inc., Glaukos Corporation, Johnson and Johnson, Labticion ...